A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors

Clinical trial NCT01106508 · COMPLETED

Trial details

NCT number: NCT01106508
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Recurrent or Refractory Medulloblastoma Locally Advanced or Metastatic Basal Cell Carcinoma

Start date: 2010-10-01
Primary completion: 2015-06-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.